Geiparvarin

Overview

Geiparvarin is an anticancer agent and an inhibitor of MAO-B ( pIC 50 = 6.84 μM). Geiparvarin exerts anti-tumor effects by downregulating COX2 expression and inhibiting angiogenesis. Geiparvarin blocks the cell cycle at the G 1 phase and induces apoptosis of cancer cells. Geiparvarin has anti- microtubule activity and destroys the cytoskeleton to exert anti-proliferative effects. Geiparvarin has research significance for lung cancer , leukemia, and breast cancer .

Application

Products | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Immunology/Inflammation | Products > Signaling Pathways > Cytoskeleton | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Drug Resistance | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Microtubule/Tubulin | Products > Signaling Pathways > Monoamine Oxidase | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > COX | Products > Signaling Pathways > Caspase

Product Information

• Catalog No.: HY-N15657
• CAS No.: 36413-91-9
• Molecular Formula: C19H18O5
• Molecular Weight: 326.34
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source